Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Extended interval dosing of ocrelizumab modifies the repopulation of B cells without altering the clinical efficacy in multiple sclerosis.
J Neuroinflammation. 2023 Sep 26;20(1):215. doi: 10.1186/s12974-023-02900-z.
J Neuroinflammation. 2023.
PMID: 37752582
Free PMC article.
Ocrelizumab concentration and antidrug antibodies are associated with B-cell count in multiple sclerosis.
Toorop AA, Hogenboom L, Bloem K, Kocyigit M, Commandeur NWM, Wijnants A, Lissenberg-Witte BI, Strijbis EMM, Uitdehaag BMJ, Rispens T, Killestein J, van Kempen ZLE.
Toorop AA, et al. Among authors: hogenboom l.
J Neurol Neurosurg Psychiatry. 2023 Jun;94(6):487-493. doi: 10.1136/jnnp-2022-330793. Epub 2023 Jan 24.
J Neurol Neurosurg Psychiatry. 2023.
PMID: 36693720
Item in Clipboard
Longitudinal SARS-CoV-2 humoral response in MS patients with and without SARS-CoV-2 infection prior to vaccination.
van Dam KPJ, Hogenboom L, Stalman EW, Kummer LYL, Steenhuis M, Keijser JBD, Brinke AT, van Ham SM, Kuijpers TW, Rispens T, Wieske L, Eftimov F, Strijbis EM, Killestein J, van Kempen ZLE.
van Dam KPJ, et al. Among authors: hogenboom l.
Front Neurol. 2022 Nov 10;13:1032830. doi: 10.3389/fneur.2022.1032830. eCollection 2022.
Front Neurol. 2022.
PMID: 36438945
Free PMC article.
Item in Clipboard
Ocrelizumab Concentration Is a Good Predictor of SARS-CoV-2 Vaccination Response in Patients with Multiple Sclerosis.
van Kempen ZLE, Hogenboom L, Toorop AA, Steenhuis M, Stalman EW, Kummer LYL, van Dam KPJ, Bloem K, Ten Brinke A, van Ham SM, Kuijpers TW, Wolbink GJ, Loeff FC, Wieske L, Eftimov F, Rispens T, Strijbis EMM, Killestein J; T2B! immunity against SARS-CoV-2 study group.
van Kempen ZLE, et al. Among authors: hogenboom l.
Ann Neurol. 2023 Jan;93(1):103-108. doi: 10.1002/ana.26534. Epub 2022 Nov 2.
Ann Neurol. 2023.
PMID: 36250739
Free PMC article.
Item in Clipboard
Stable multiple sclerosis patients on anti-CD20 therapy should go on extended interval dosing: NO.
van Kempen ZL, Hogenboom L, Killestein J.
van Kempen ZL, et al. Among authors: hogenboom l.
Mult Scler. 2022 Apr;28(5):693-695. doi: 10.1177/13524585211064441. Epub 2022 Jan 7.
Mult Scler. 2022.
PMID: 34994665
No abstract available.
Item in Clipboard
Cite
Cite